1. "Breast Medicine Service"
  2. "Cancer Research"
Formats
  1. Meeting Abstract (427)
  2. Journal Article (51)
  3. Miscellaneous (1)
Groups
  1. Breast Medicine Service (479)
  2. Department of Medicine (479)
  3. Solid Tumor Oncology Division (479)
  4. GSK Faculty (230)
  5. Survivorship Research (224)
  6. Human Oncology and Pathogenesis Program (153)

More Groups

People
  1. Clifford Hudis (108)
  2. Neal Rosen (98)
  3. Larry Norton (79)
  4. Sarat Chandarlapaty (64)
  5. David Solit (60)
  6. Sujata Patil (52)

More People

Years
  1. 2022 (15)
  2. 2021 (38)
  3. 2020 (58)
  4. 2019 (42)
  5. 2018 (37)
  6. 2017 (25)

More Years

Publications
  1. Cancer Research (479)
Publishers
  1. American Association for Cancer Research (479)

Results (479)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Amcenestrant, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/HER2-advanced breast cancer (aBC): Combined biomarker analyses from a phase 1/2 study in postmenopausal women and a phase 1 study in postmenopausal Japanese women
    Meeting Abstract

    Iwata, H.; Bardia, A.; Lord, S.; Linden, H. M.; Campone, M.; Tamura, K.; Yonemori, K.; Mukohara, T.; Combeau, C.; Ternes, N.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The lung pro-thrombotic niche drives cancer-associated thromboembolism via exosomal ITGB2
    Meeting Abstract

    Lucotti, S.; Ogitani, Y.; Kenific, C. M.; Bojmar, L.; Cioffi, M.; Lauritzen, P.; Molina, H.; Heissel, S.; Lengel, H. B.; Jing, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Loss of glutathione peroxidase 2 promotes epithelial to mesenchymal transition and breast cancer metastasis
    Meeting Abstract

    Ren, Z.; Liang, H.; Dharmaratne, M.; Morales-Gallego, M.; Fard, A. T.; Mar, J.; Suyama, K.; Benard, O.; Prystowsky, M. B.; Norton, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • NR2F2 mediates cell growth and endocrine resistance in NF1 loss, ER+ breast cancer
    Meeting Abstract

    Cai, Y.; Zhao, P.; Wu, F.; Shao, H.; Razavi, P.; Xu, G.; Scaltriti, M.; Chandarlapaty, S.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • TCF7 promotes a mammary cancer-stem-like phenotype leading to metastasis via potentiation of a hybrid epithelial/mesenchymal (E/M) phenotype
    Meeting Abstract

    Liang, H.; Benard, O.; Ren, Z.; Suyama, K.; Norton, L.; Hazan, R. B.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save